- Report
- October 2024
- 194 Pages
Global
From €3371EUR$3,545USD£2,834GBP
€3745EUR$3,939USD£3,149GBP
- Report
- August 2024
- 136 Pages
Global
From €2851EUR$2,999USD£2,398GBP
- Report
- July 2024
- 175 Pages
Global
From €4754EUR$5,000USD£3,998GBP
- Report
- April 2023
- 147 Pages
Global
From €4706EUR$4,949USD£3,957GBP
- Report
- February 2024
- 110 Pages
Global
From €4516EUR$4,750USD£3,798GBP
- Report
- January 2022
- 111 Pages
Global
From €4516EUR$4,750USD£3,798GBP
- Report
- March 2021
- 183 Pages
Global
From €3423EUR$3,600USD£2,878GBP
- Report
- October 2024
- 22 Pages
Uzbekistan
From €995EUR$1,121USD£866GBP
- Report
- September 2024
- 25 Pages
Colombia
From €995EUR$1,121USD£866GBP
- Report
- May 2022
- 109 Pages
South Africa
From €2710EUR$2,850USD£2,279GBP
- Report
- October 2024
- 23 Pages
Kenya
From €995EUR$1,121USD£866GBP
- Report
- March 2024
- 132 Pages
Global
From €903EUR$950USD£760GBP

The Cough Syrup market is a segment of the Cough and Cold Drugs industry. It is composed of products that are used to treat the symptoms of coughs, such as sore throat, chest congestion, and mucus buildup. These products are available in a variety of forms, including liquid, tablets, and capsules. They are typically formulated with active ingredients such as dextromethorphan, guaifenesin, and codeine. In addition, many cough syrups contain additional ingredients such as antihistamines, decongestants, and expectorants.
Cough syrups are widely available over-the-counter and are often used to treat mild to moderate coughs. They are also used to treat more severe coughs, such as those caused by bronchitis or pneumonia. However, in such cases, a doctor should be consulted before taking any medication.
Some of the major companies in the Cough Syrup market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Novartis, and Sanofi. These companies produce a wide range of cough syrups, including those with and without codeine. Show Less Read more